Other formats:
BibTeX
LaTeX
RIS
@article{1683659,
author = {Bosák, Juraj and Hrala, Matěj and Micenková, Lenka and Šmajs, David},
article_location = {ABINGDON},
article_number = {3},
doi = {http://dx.doi.org/10.1080/14787210.2020.1816824},
keywords = {Antimicrobials; bacteriocin; colicin; microcin; Escherichia; E; coli; probiotic; Shigella; virulence; diarrhea},
language = {eng},
issn = {1478-7210},
journal = {EXPERT REVIEW OF ANTI-INFECTIVE THERAPY},
title = {Non-antibiotic antibacterial peptides and proteins ofEscherichia coli: efficacy and potency of bacteriocins},
url = {https://www.tandfonline.com/doi/full/10.1080/14787210.2020.1816824},
volume = {19},
year = {2021}
}
TY - JOUR
ID - 1683659
AU - Bosák, Juraj - Hrala, Matěj - Micenková, Lenka - Šmajs, David
PY - 2021
TI - Non-antibiotic antibacterial peptides and proteins ofEscherichia coli: efficacy and potency of bacteriocins
JF - EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
VL - 19
IS - 3
SP - 309-322
EP - 309-322
PB - TAYLOR & FRANCIS LTD
SN - 14787210
KW - Antimicrobials
KW - bacteriocin
KW - colicin
KW - microcin
KW - Escherichia
KW - E
KW - coli
KW - probiotic
KW - Shigella
KW - virulence
KW - diarrhea
UR - https://www.tandfonline.com/doi/full/10.1080/14787210.2020.1816824
L2 - https://www.tandfonline.com/doi/full/10.1080/14787210.2020.1816824
N2 - Introduction The emergence and spread of antibiotic resistance among pathogenic bacteria drives the search for alternative antimicrobial therapies. Bacteriocins represent a potential alternative to antibiotic treatment. In contrast to antibiotics, bacteriocins are peptides or proteins that have relatively narrow spectra of antibacterial activities and are produced by a wide range of bacterial species. Bacteriocins ofEscherichia coliare historically classified as microcins and colicins, and, until now, more than 30 different bacteriocin types have been identified and characterized. Areas covered We performed bibliographical searches of online databases to review the literature regarding bacteriocins produced byE. coliwith respect to their occurrence, bacteriocin role in bacterial colonization and pathogenicity, and application of their antimicrobial effect. Expert opinion The potential use of bacteriocins for applications in human and animal medicine and the food industry includes (i) the use of bacteriocin-producing probiotic strains, (ii) recombinant production in plants and application in food, and (iii) application of purified bacteriocins.
ER -
BOSÁK, Juraj, Matěj HRALA, Lenka MICENKOVÁ and David ŠMAJS. Non-antibiotic antibacterial peptides and proteins ofEscherichia coli: efficacy and potency of bacteriocins. \textit{EXPERT REVIEW OF ANTI-INFECTIVE THERAPY}. ABINGDON: TAYLOR \&{} FRANCIS LTD, 2021, vol.~19, No~3, p.~309-322. ISSN~1478-7210. Available from: https://dx.doi.org/10.1080/14787210.2020.1816824.
|
